Treatment of neurological deficits in the striatum or substanta nigra pars compacta

Details for Australian Patent Application No. 2005289591 (hide)

Owner Ethicon, Inc.

Inventors Messina, Darin J.; Mistry, Sanjay

Agent Callinan

Pub. Number AU-B-2005289591

PCT Pub. Number WO2006/036919

Priority 10/952,064 28.09.04 US

Filing date 26 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 12 May 2011

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/036919 Priority application(s): WO2006/036919

12 May 2011 Application Accepted

  Published as AU-B-2005289591

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289594-Srage mimetibody, compositions, methods and uses

2005289588-RNAi modulation of ApoB and uses thereof